Drug intelligence / Profile preview

IL-6 neutralization antibody

Development stage
Unknown
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous, Subcutaneous
01

Overview

An IL-6 neutralization antibody (or IL-6 neutralizing antibody) is a class of monoclonal antibodies designed to bind directly to interleukin-6 (IL-6) and neutralize its biological activity. IL-6 is a pleiotropic pro-inflammatory cytokine that plays a pivotal role in immune regulation, hematopoiesis, and inflammation. By binding to IL-6, these antibodies prevent it from interacting with the membrane-bound or soluble IL-6 receptor (IL-6R), thereby blocking the assembly of the IL-6/IL-6R/gp130 signaling complex and inhibiting downstream JAK/STAT and MAPK signaling pathways. This therapeutic approach is widely utilized to treat chronic inflammatory and autoimmune diseases, such as rheumatoid arthritis, multicentric Castleman disease, and cytokine release syndrome (CRS).

Other names
anti-IL-6 antibodyanti-IL6 antibodyanti-IL 6 antibodyanti-IL-6 neutralizing antibodyanti-IL6 neutralizing antibodyanti-IL 6 neutralizing antibodyIL-6 neutralizing antibodyIL6 neutralizing antibodyIL 6 neutralizing antibodyinterleukin-6 neutralization antibodyinterleukin6 neutralization antibodyinterleukin 6 neutralization antibodyinterleukin-6 neutralizing antibodyinterleukin6 neutralizing antibodyinterleukin 6 neutralizing antibody
02

Targets

IL-6 (Interleukin 6)

Beyond the preview

Go deeper on IL-6 neutralization antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IL-6 neutralization antibody.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call